Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2741 results about "Extracellular vesicles" patented technology

Extracellular vesicle. Extracellular vesicles (EVs) are lipid bilayer-delimited particles that are naturally released from a cell and, unlike a cell, cannot replicate.

Inflammation-targeting bionic extracellular vesicle as well as preparation method and application thereof

The invention discloses an inflammation-targeting bionic extracellular vesicle as well as a preparation method and application thereof, and particularly relates to the field of medicines. According to the invention, a new generation of aminoglycoside antibiotic teicoplanin (Teic), which is high in albumin binding rate and weak in intracellular antibacterial effect, is loaded on neutrophil-derived extracellular vesicles (NEV) with natural drug carrying capacity and inflammatory response chemotactic capacity to prepare the drug-loaded vesicles (Teic-NEV), wherein the new generation of aminoglycoside antibiotic teicoplanin (Teic) is used for loading the neutrophil-derived extracellular vesicles (NEV). The drug-loaded extracellular vesicle Teic-NEV can be used for targeted therapy of cells and tissues infected by MRSA (Methicillin-Resistant Staphylococcus Aureus). In vitro, the Teic (at) NEV can be used for destroying MRSA mature biological membranes and killing intracellular MRSA. According to the invention, the in-vivo and in-vitro biological safety of the TeicatNEV is evaluated. Therefore, the invention provides a certain theoretical basis for the application of NEV-based drug delivery in the field of intracellular bacteria treatment, and also provides a new treatment strategy for in-vivo targeted treatment.
Owner:ZHEJIANG UNIV

Methods for isolating surface marker displaying agents

The invention relates to method and kits for highly specific isolation of extracellular vesicles (EVs) by targeting at least two EV surface markers. The invention further relates to methods and kits for analyzing EVs and their contents.
Owner:MESO SCALE TECH LLC

Treatment of amyotrophic lateral sclerosis with extracellular vesicle composition

PCT designated stage expiredWO2024254540A2Nervous disorderMuscular disorderExtracellular vesicleMedicine
Disclosed are methods of treating amyotrophic lateral sclerosis in a subject by administering a therapeutic MSC secretome product made by a method comprising culturing bone marrow-derived MSCs under conditions that include oxygen tension below 5% and a culture media with a pH below 7.
Owner:DIRECT BIOLOGICS LLC

Blood extracellular vesicle miRNA combination and application thereof in early diagnosis of lung cancer

The invention discloses a blood extracellular vesicle miRNA (micro Ribonucleic Acid), miRNAs (micro Ribonucleic Acid) hsa-miR-150-3p, hsa-miR-150-5p, hsa-miR-335-3p, hsa-miR-375, hsa-miR-4433b-5p and hsa-miR-4732-5p, which can be used as biomarkers for early diagnosis of lung cancer, so that the blood extracellular vesicle miRNA can be used for preparing a chip, a detection reagent or a detection kit for early diagnosis of lung cancer. The blood extracellular vesicle miRNA biomarker disclosed by the invention has high sensitivity and high specificity on early diagnosis of lung cancer, so that false positive caused by a traditional diagnosis method can be reduced, and the miRNA biomarker has a potential good clinical application value.
Owner:江西省肿瘤医院(江西省第二人民医院 江西省癌症中心) +1

Treatment of complex regional pain syndrome with extracellular vesicle composition

PCT designated stage expiredWO2024254459A2Nervous disorderPeptide/protein ingredientsExtracellular vesiclePain syndrome
Disclosed are methods of treating complex regional pain syndrome in a subject by administering a therapeutic MSC secretome product made by a method comprising culturing bone marrow-derived MSCs under conditions that include oxygen tension below 5% and a culture media with a pH below 7.
Owner:DIRECT BIOLOGICS LLC

Method for extracting extracellular vesicles from dry sanguisorba officinalis rhizomes and application of extracellular vesicles

The invention discloses a method for extracting extracellular vesicles from dried Sanguisorba officinalis rhizomes and application of the extracellular vesicles, and relates to the technical field of molecular biology and biomedicine.The method comprises the following steps that S1, rehydration is conducted, specifically, the dried Sanguisorba officinalis rhizomes are subjected to liquid nitrogen quick freezing and then ground into powder at the low temperature, the powder and hydration liquid are mixed according to the proportion of 1: 10 (w / v), the mixture is slowly stirred for 2-4 h at the temperature of 4 DEG C, and the extracellular vesicles are obtained; removing large-particle impurities by using sterile gauze or a filter screen, and collecting filtrate; according to the method, through the synergistic effect of multiple enzymolysis and in combination with cellulase, pectinase and the like, the degradation efficiency is remarkably improved, meanwhile, EDTA is chelated with metal ions, and the enzymolysis effect is enhanced. Short-time alternating ultraviolet light is introduced to activate'dormant 'vesicles, so that the yield and the biological activity are improved. Secondly, multiple protection mechanisms, such as vitamin C, EDTA (Ethylene Diamine Tetraacetic Acid), cane sugar, BSA (Bovine Serum Albumin) and an ultraviolet protective agent are adopted, so that the integrity and the biological activity of the vesicles are ensured.
Owner:SHENZHEN UNIV GENERAL HOSPITAL

Device and method for manipulation of extracellular vesicles

The invention relates to a method for isolating a biomolecule. A liquid sample comprising the biomolecule is contacted with an electrically conductive surface. The surface carries a chemical modification facilitating retention of said biomolecule, or an electrical retention potential is applied to said surface. The biomolecule is released by applying a voltage to the surface. The invention further relates to a device comprising a chamber configured for receiving a liquid sample, wherein a first surface of said chamber is a working electrode formed by a high-surface, electrochemically active material embedded in a non-electrically conductive polymer matrix. The device further comprises a counter electrode and connections to a voltage source. The invention further relates to a device and method for loading an extracellular vesicle with cargo molecules.
Owner:ETH ZURICH

Diagnostic and treatment monitoring based on blood-brain barrier disruption

The disclosure provides technologies that permit detection and / or characterization of brain biomarkers (e.g., disease-associated biomarkers) in non-CNS samples, including by liquid biopsy (e.g., blood, serum, etc.). Among other things, the present disclosure demonstrates that ultrasound opening of the blood brain barrier can achieve detectable increases in brain-derived materials (e.g., brain-derived proteins, neuron-derived extracellular vesicles, and / or cell-free DNA) in readily-sampled systemic liquids.
Owner:INSIGHTEC

Preparation method and application of universal renewable immunoaffinity magnetic beads

The invention discloses a preparation method and application of a universal renewable immunoaffinity magnetic bead, and belongs to the technical field of chemical detection.The preparation method comprises the steps that firstly, an engineered bacteriophage H6G5-M13 is constructed, then a polypeptide module is coupled to the engineered bacteriophage H6G5-M13, the polypeptide module comprises a part A, a part B and a part C from the N end to the C end, the part A is a target object recognition sequence located at the N end, and the part C is a target object recognition sequence located at the C end; the part B is a selectively added connecting sequence, the part C is an LPXTG substrate sequence and is located at the C end, and X refers to any amino acid; finally, the engineered bacteriophage is directionally coupled to the Ni < 2 + >-IDA magnetic bead through the action of Ni-6His, and then the universal and novel immunoaffinity magnetic bead is formed. The universal and replaceable immunoaffinity magnetic bead prepared by the method can be used for preparing a chemical detection reagent, and can also be used for capturing, releasing and sensing detection of cells and extracellular vesicles.
Owner:NORTHEASTERN UNIV CHINA

Drug delivery carrier based on extracellular vesicles and application thereof

The invention relates to a drug delivery carrier based on extracellular vesicles and application thereof.The drug delivery carrier contains extracellular vesicle scaffold protein and recombinant membrane fusion protein, the recombinant membrane fusion protein comprises a first fragment and a second fragment, the amino acid sequence of the first fragment is shown as SEQ ID NO: 5, and the amino acid sequence of the second fragment is shown as SEQ ID NO: 6; the second fragment has n amino acids, the sequence of the second fragment is the sequence of the first n amino acids at the N end of the amino acid sequence as shown in SEQ ID NO: 7, and n is an integer between 50 and 200. According to the drug delivery carrier disclosed by the invention, the efficiency of releasing drug active molecules before reaching lysosome is remarkably improved, and the drug effect of extracellular vesicle drugs can be improved.
Owner:苏州唯思尔康科技有限公司

Traditional Chinese medicine meridian prescription system for analyzing extracellular vesicles based on multi-omics integration

The invention provides a traditional Chinese medicine meridian prescription system based on multi-omics integration analysis of extracellular vesicles, and the system comprises a data collection module which is used for collecting biopsy sample information of different groups of individuals based on related experiments and literatures of traditional Chinese medicine meridian prescription treatment; the data processing module is used for obtaining and preprocessing extracellular vesicle data and intestinal flora data based on biopsy sample information; the multi-omics integration module is used for obtaining multi-omics integration data; the discovery and verification module is used for obtaining the potential menstrual prescription drug effect evaluation biomarker and performing experimental verification on the potential menstrual prescription drug effect evaluation biomarker to obtain a verification result; and the system biology application module is used for obtaining a regulatory mechanism of the extracellular vesicles in a biological system based on construction of a gene-protein-metabolite interaction network. The invention can comprehensively reveal the pharmacodynamic mechanism of the traditional Chinese medicine menstrual prescription, and provides strong technical support and application prospect for the modern, scientific and internationalized development of traditional Chinese medicines.
Owner:SHANGHAI UNIV

Method for extracting extracellular vesicles from dried traditional Chinese medicine product

The embodiment of the invention discloses a method for extracting extracellular vesicles from a traditional Chinese medicine dry product. The method comprises the following steps: taking a dry traditional Chinese medicine product as a raw material, and sequentially performing crushing, soaking, first-order enzymolysis, wall breaking, differential centrifugation, second-order enzymolysis, high-speed centrifugation, ultracentrifugation and ultrafiltration enrichment to obtain the extracellular vesicles. A two-step enzymolysis method is adopted in the enzymolysis process, impurities are removed to the maximum extent in a sequence difference enzymolysis mode, and the structure and function stability of the exosome are protected. According to the invention, the differential centrifugation and the enzymolysis method are alternately used, so that impurities with different sizes and different properties can be removed more thoroughly. According to the method, the cost is strictly controlled, the exosome purification efficiency is relatively high, the concentration of the obtained dry exosome is relatively high, and the operability is extremely high.
Owner:CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE

Treatment of traumatic brain injury with extracellular vesicle composition

Disclosed are methods of treating traumatic brain injury in a subject by administering a therapeutic MSC secretome product made by a method comprising culturing bone marrow-derived MSCs under conditions that include oxygen tension below 5% and a culture media with a pH below 7.
Owner:DIRECT BIOLOGICS LLC

Drug-loaded callicarpa nudiflora-derived extracellular vesicle as well as preparation method and application thereof

The invention provides a drug-loaded callicarpa nudiflora-derived extracellular vesicle as well as a preparation method and application thereof, and relates to the technical field of pharmaceutical preparations. The drug-loaded callicarpa nudiflora-derived extracellular vesicle has relatively high encapsulation efficiency and drug loading rate and good gastrointestinal tract stability and biocompatibility, can target a colitis disease part to reduce adverse reaction of a drug and improve the curative effect, solves the problem that the drug is insoluble in water, and can be used for preparing the drug-loaded callicarpa nudiflora-derived extracellular vesicle. The invention provides a novel drug delivery strategy for treating the ulcerative colitis, and is expected to become an effective strategy for clinically treating the ulcerative colitis, thereby achieving the effects of synergistically treating the ulcerative colitis and improving the effectiveness and safety of drug delivery.
Owner:NANCHANG UNIV

Application of lily extracellular vesicles in preparation of tumor treatment drugs

The invention belongs to the technical field of biological agents, and particularly discloses application of lily extracellular vesicles in preparation of tumor treatment drugs. The preparation method of the lily extracellular vesicles comprises the following steps: S1, juicing lily bulb tissues, and filtering to obtain a lily bulb stock solution; s2, treating the lily bulb stock solution obtained in the step S1 to obtain a lily extracellular vesicle extracting solution; s3, concentrating and purifying the lily extracellular vesicle extracting solution obtained in the step S2 to obtain lily extracellular vesicles; wherein in the step S2, the treatment comprises centrifugation and filter membrane filtration. The lily extracellular vesicle provided by the invention can effectively promote polarization of M2-type macrophages to M1-type macrophages, shows remarkable immunoregulation ability, is good in biocompatibility, and has the potential of preparing anti-cancer drugs.
Owner:ZHEJIANG SCI-TECH UNIV

Sperm injury repair model and establishment method thereof

The invention belongs to the technical field of biological medicines, and particularly relates to a sperm injury repair model and an establishment method thereof. Comprising the following steps: step 1, establishing a sperm lead poisoning model; and 2, establishing a lead poisoning sperm repair model. The method for establishing the lead poisoning sperm repair model in the step 2 comprises the following steps: (1) preparing a preparation for optimizing sperm functions in an extracellular vesicle way; (2) repairing the damaged sperms by using the preparation for optimizing the sperm function through the extracellular vesicles; and (3) detecting the activity of the repaired sperms. In the invention, by establishing a sperm injury repair model and adopting an extracellular vesicle modification technology, the key functional protein is introduced into the extracellular vesicle, and the method has important significance on auxiliary researches such as development and research of related drugs for improving sperm injury and improving sperm motility of asthenospermia patients in vitro.
Owner:THE OBSTETRICS & GYNECOLOGY HOSPITAL OF FUDAN UNIV

Treatment of infertility with extracellular vesicle composition

Disclosed are methods of treating infertility or increasing fertility of a female subject by administering a therapeutic MSC secretome product made by a method comprising culturing bone marrow-derived MSCs under conditions that include oxygen tension below 5% and a culture media with a pH below 7.
Owner:DIRECT BIOLOGICS LLC

Antigen delivery platform and methods of use

Provided herein are compositions and methods for inducing an immune response in a subject, wherein the compositions comprise apoptotic cells, extracellular vesicles (EVs), and combinations thereof. Various compositions comprising mRNA encoding a microbial antigen are also provided. Further provided herein are compositions engineered to overexpress the human arrestin domain containing protein 1 [ARRDC1].
Owner:INTIMA BIOSCIENCE INC

Application of Ackermania muciniphila or extracellular vesicles thereof in preparation of medicine for alleviating alcoholic ischemic necrosis of femoral head

The invention belongs to the field of biological medicines, and discloses an application of Akkermansia muciniphila or an extracellular vesicle of the Akkermansia muciniphila in preparation of a medicine for alleviating the ischemic necrosis of the alcoholic femoral head. Based on the pathogenesis characteristics of the AIONFH, the Akk bacteria and the extracellular vesicles thereof are used for treating the AIONFH for the first time, the molecular mechanism of the Akk bacteria and the extracellular vesicles thereof for regulating and controlling the intestinal tract-skeleton axis function, inhibiting bone cell apoptosis and improving the bone trabecula microstructure is deeply researched, the anti-pressure ability of bone tissue is improved, and the research blank in the field is filled. Compared with a traditional treatment method, the osteonecrosis pathological change is improved through a single way, and a novel multi-target treatment strategy is provided from multiple aspects of regulating inflammatory response, recovering bone metabolism balance, promoting intraosseous blood supply and the like.
Owner:XIANGYA HOSPITAL CENT SOUTH UNIV

Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles

Disclosed are methods of treating perianal fistula a subject by administering a therapeutic MSC secretome product made by a method comprising culturing bone marrow-derived MSCs under conditions that include oxygen tension below 5% and a culture media with a pH below 7.
Owner:DIRECT BIOLOGICS LLC

Application of protein in small extracellular vesicles as prostate cancer diagnostic marker

ActiveCN119125561AHigh AUC valueHigh specificity and sensitivityMaterial analysisAntigenPsa antigen
The invention discloses application of small extracellular endovesicular protein as a prostatic cancer diagnostic marker, and is characterized in that the small extracellular endovesicular protein is plasma sample sEV protein LAMB1 and / or urine sample sEV protein Histone H4, and the plasma sample sEV protein LAMB1 is applied as a metastatic prostatic cancer diagnostic marker. The sEV protein LAMB1 of the plasma sample is combined with a prostate specific antigen to serve as metastatic prostate cancer; the application of the sEV protein Histone H4 in the urine sample as a prostate cancer grading diagnosis marker, the application of the sEV protein Histone H4 in the urine sample as a high-risk prostate cancer diagnosis marker and the application of the combination of the sEV protein Histone H4 in the urine sample and a prostate specific antigen as the high-risk prostate cancer diagnosis marker have the advantages of high sensitivity and strong specificity.
Owner:NINGBO FIRST HOSPITAL

Method for isolating and / or enriching extracellular vesicles

The invention provides a method for separating extracellular vesicles from a milk source, which comprises the step of adding a dispersing agent before adding a precipitator into the milk source to precipitate casein so as to reduce the wrapping of protein precipitation on the extracellular vesicles and improve the yield of the extracellular vesicles, thereby obtaining a milk source extract rich in the extracellular vesicles.
Owner:BEIJING CHANGXIANG BIO-PHARM CO LTD

Typing analysis method for extracellular vesicles secreted by tumor cells and immune cells

The invention discloses a typing analysis method for extracellular vesicles secreted by tumor cells and immune cells, which comprises the following steps: designing a PD-L1 protein recognition aptamer PD-L1-L, an EpCAM protein recognition aptamer EpCAM-L and a molecular beacon according to different expression levels of surface markers of the extracellular vesicles (PD-L1 + and EpCAM +) derived from the tumor cells and the extracellular vesicles (PD-L1 + and EpCAM-) derived from the immune cells; when the DNA probe recognizes the extracellular vesicles, fluorescence of the Cy5-PD-L1-L aptamer of the tumor cell source extracellular vesicles is quenched, a fluorescence signal of the Connector is recovered, and the immune cell source extracellular vesicles do not respond, so that the two extracellular vesicles are subjected to typing analysis. The method has the advantages that the extracellular vesicles of different cell sources can be subjected to typing analysis by using a strategy based on double aptamers and double switches, and false positive signals caused by single aptamer recognition are avoided.
Owner:XIAMEN UNIV

RELM beta pre-activated stem cell outer vesicle with high anti-inflammatory and anti-fibrosis activity

The invention belongs to the technical field of stem cell culture and exosome extraction, and provides an RELM beta pre-activated stem cell outer vesicle with high anti-inflammatory and anti-fibrosis activity. According to the method, the mesenchymal stem cells are subjected to hunger culture after being adhered to the wall and then are continuously cultured by a complete culture medium containing RELM beta factors, then supernate is collected, and the exovesicles are obtained through separation. In the preparation process of the extracellular vesicles, the paracrine function of MSC cells is promoted by the RELM beta, the secretion of anti-inflammatory and anti-fibrosis active factors is obviously activated, and the generation of the extracellular vesicles with enhanced anti-inflammatory and anti-fibrosis effects is promoted. Gene modification is not involved, toxic biochemical reagents or materials are not added, exogenous operation steps are simple and convenient, clinical application is guaranteed through sterile operation, no RELM beta residues exist after extracellular vesicle extraction, and the method is safe, non-toxic and effective.
Owner:SHANDONG QILU CELL THERAPY ENG TECH CO LTD +1